FdaApplication
NDA 210852
Identifiers
- fda_app_no: NDA210852
Properties
| Property | Value |
|---|---|
| applicant_name | AVYXA HOLDINGS LLC |
| application_type | NDA |
| approval_date | 2023-06-07 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| FRINDOVYX | CYCLOPHOSPHAMIDE | 2GM/4ML (500MG/ML) | SOLUTION;INTRAVENOUS |
| FRINDOVYX | CYCLOPHOSPHAMIDE | 500MG/ML (500MG/ML) | SOLUTION;INTRAVENOUS |
| FRINDOVYX | CYCLOPHOSPHAMIDE | 1GM/2ML (500MG/ML) | SOLUTION;INTRAVENOUS |
3 products